Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Free Cash Flow (2021 - 2025)

Biote (BTMD) has 5 years of Free Cash Flow data on record, last reported at $16.9 million in Q3 2025.

  • For Q3 2025, Free Cash Flow fell 3.97% year-over-year to $16.9 million; the TTM value through Sep 2025 reached $34.1 million, down 7.49%, while the annual FY2024 figure was $38.8 million, 58.23% up from the prior year.
  • Free Cash Flow reached $16.9 million in Q3 2025 per BTMD's latest filing, up from $3.9 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $17.9 million in Q2 2021 and bottomed at -$28.5 million in Q2 2022.
  • Average Free Cash Flow over 5 years is $6.0 million, with a median of $6.7 million recorded in 2024.
  • Peak YoY movement for Free Cash Flow: tumbled 258.68% in 2022, then skyrocketed 2106.25% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at $10.6 million in 2021, then crashed by 34.86% to $6.9 million in 2022, then fell by 25.98% to $5.1 million in 2023, then surged by 37.77% to $7.1 million in 2024, then surged by 140.28% to $16.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Free Cash Flow were $16.9 million in Q3 2025, $3.9 million in Q2 2025, and $6.2 million in Q1 2025.